Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia

Hiroshima University21 enrolled

Overview

The aim of this study is to investigate the efficacy and dose-dependency of chrysanthemum flower oil in suppressing serum uric acid.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

TRIPLE

Enrollment

Conditions

Hyperuricemia

Interventions

200 mg of chrysanthemum flower oilDIETARY_SUPPLEMENT

300 mg of chrysanthemum flower oilDIETARY_SUPPLEMENT

400 mg of chrysanthemum flower oilDIETARY_SUPPLEMENT

Eligibility

Sex: MALEMin age: 30 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Serum uric acid 6.8-8.9 mg/dL Exclusion Criteria: * Taking anti-hyperuricemic drugs * History of gouty attack * Taking drugs or functional food that may affect serum uric acid level * Hypertention, hyperlipidemia, or diabetes millitus * Participation in any clinical trial within 90 days of the commencement of the trial * Renal or hepatic dysfunction * Heart disease * History of severe disease and/or major surgery

Locations (1)

Hiroshima University

Hiroshima, Japan

Outcomes

Primary Outcomes

Change in serum uric acid from baseline

Time frame: Every 4 weeks (Overall 8 weeks)

Change in uric acid clearance from baseline

Time frame: Every 4 weeks (Overall 8 weeks)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.